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Background: Lymphatic filariasis (LF), a vector-borne parasitic disease, is endemic in several parts of India and
mostly affects the poor or those with a low-income. The disease results in huge numbers of morbidities, disabilities,
and deaths every year. Association of co-infection with other pathogens makes the condition more severe.
Although co-infection is becoming a growing area of research, it is yet to emerge as a frontier research topic in
filarial research specifically. This study reports the occurrence of a fungal infection in a large number of patients
suffering from bancroftian filariasis in two districts of West Bengal, India.
Methods: Nocturnal blood samples from filarial patients containing parasites and fungus were initially co-cultured,
and further the fungus was isolated and characterized. Molecular identification of the isolate was carried out by
PCR-based selective amplification and sequencing of highly-conserved D1/D2 region of 26S rDNA, whereas
pathogenicity was determined by amplification of the RPS0 gene. A phylogenetic tree was constructed to study the
relationship between the isolate and common pathogenic yeasts. The isolate was studied for antibiotic sensitivity,
whereas morphological characterization was performed by microscopic techniques.
Results: The isolate was identified as Pichia guilliermondii and this fungus was found to exist in co-infection with
Wuchereria bancrofti in filarial patients. The fungus showed resistance to azole antifungals, griseofulvin, and,
amphotericin B, whereas significant susceptibility was evident in cases of nystatin and cycloheximide. A total of 197
out of 222 patients showed this co-infection.
Conclusion: This study revealed, for the first time, that P. guilliermondii exists as a co-infection in microfilaraemic
individuals living in a filarial endemic zone. The findings are important and have relevance to human health,
especially for filarial patients.
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Lymphatic filariasis (LF), a vector-borne disease mainly
caused by the filarial parasites– namely Wuchereria ban-
crofti, Brugia malayi, and Brugia timori-has become a* Correspondence: spsinhababu@gmail.com
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article, unless otherwise stated.global problem that constitutes 120 million infections
per year in 81 tropical countries [1]. It is the world’s sec-
ond leading cause of long-term disability. Out of the
total disease burden of LF, W. bancrofti alone accounts
for 90% and this form of LF is termed ‘bancroftian filar-
iasis’ [2]. Currently, one-third of the affected persons are
from South Asia and another third from Africa, while
one-sixth of the world’s population is at risk of infection
[1]. It is a disease mostly of the poor, which significantly
affects this group’s ability to earn an income, and this
has led to its inclusion on the list of neglected tropicaltral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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social impacts wherever it is endemic; disfiguring and/or
incapacitating more than 40 million individuals, their fam-
ilies, and the endemic communities. Particularly in the In-
dian subcontinent, the disease affects the work time of
infected patients and thereby costs the National Treasury
a minimum of US$842 million per year [3]. Lymphatic Fil-
ariasis is endemic in several parts of India, including 250
districts in 20 states and six union territories (UTs), con-
tributing 40% to the global disease burden [3]. The causa-
tive agents of LF i.e. filarial parasites live in the body cavity
or tissues of vertebrate hosts where they parasitize the
lymphatics, which results in the obstruction of the lymph-
atic vessels, incompetence, lymphostasis, lymphatic dys-
function (hydrocele and lymphedema), and interstitial
fibrosis, followed by immunological dysfunction and in-
flammation which results in elephantiasis [4]. This disease
also promotes vulnerability to opportunistic infections [5],
particularly during the progression of lymphedema from
chronic filarial infection. Development of elephantiasis is
caused by the long-term recurrent secondary infections by
opportunistic microbes [4].
Opportunistic microbial infections are very common
in infectious diseases that suppress the host immune sys-
tem, and promote secondary infections that are of major
concern as they make the host weaker or create a life-
threatening condition [6,7]. Different bacteria, viruses, and
fungi, especially Candida yeasts, have been characterized
as opportunistic pathogens [8]. The epidemiology of yeast
infections is rapidly evolving as co-infection in patients
suffering from primary infectious diseases [9]. Although
rare, non-albicans Candida (NAC) spp. are emerging as
potential opportunistic pathogens, among which Pichia
guilliermondii (formerly known as Candida guilliermondii
or Meyerozyma guilliermondii) is one of the 15 yeast spe-
cies related to human diseases [9,10]. It is commonly iso-
lated from clinical specimens such as phlegm, wounds,
sputum, and blood [11]. Although P. guilliermondii is least
pathogenic compared to the other fungi of the Candida
family, it can still be responsible for life-threatening in-
fections in immunocompromised hosts [9,12]. It consti-
tutes 35–65% of all candidaemias in the general patient
population and is mostly evident in cancer patients,
bone marrow transplant recipients and, to a lesser de-
gree, in intensive care unit patients, children, and surgi-
cal and HIV-positive patients [13]. As reported by Horn
et al. [14], 1–5% prevalence of Candida infection is con-
tributed by P. guilliermondii. The large-scale studies of
candidaemia between 1999 and 2006 found that around
15% of a total of 9,717 cases were due to the P. guillier-
mondii infection [12]. Dick et al. [15] previously reported
death due to disseminated candidiasis caused by the P.
guilliermondii infection. Recently, this pathogen has been
reported to cause infection in the knee of a patient lackingpredisposing factors [16]. Occurrence of P. guilliermondii
out of the total Candida isolates in different geographic
locations is 1.1% in the Asia Pacific, 1.0% in Europe, 3.7%
in Latin America, and 0.6% in North America [17].
Particularly for filariasis, Ormerod et al. [18] reported
an unusual and chronic anaerobic urinary infection in the
filarial patients caused by Bacteroides melaninogenicus, B.
fragilis, Peptococcus prevotii, and Propionibacterium gran-
ulosum, passed from the abnormal lymphatics. Date et al.
[19] reported severe lymphocytopenia, extensive mucosal
candidiasis, and disseminated cryptococcosis in patients
with long-standing filarial chyluria with immunological
abnormalities. Recently, Metenou et al. [20] reviewed
experimental findings on filaria/mycobacteria or filaria/
Plasmodium co-infections in filarial patients. Although
studied less, fungal infections are believed to cause prob-
lems in LF such as edema-causing skin folds and skin tears
[21]. However, occurrence of P. guilliermondii has neither
been reported from India nor from the peripheral blood
stream of any microfilaraemic patient. This study reports,
for the first time, the co-infection of P. guilliermondii with
W. bancrofti in the blood of microfilaraemic patients living
in the filaria endemic zone in West Bengal, India.
Methods
Study area and population
This study was conducted in two rural districts, namely
Bankura (23° 14′ N and 87° 07′ E) and Birbhum (24° 35′
N and 88° 1′ 40″ E), in West Bengal, India. These regions
were previously reported as endemic for lymphatic filaria-
sis (LF), with more than 14% prevalence [22,23]. The
study was approved by the Human Ethical Committee of
the Sub-Divisional Hospital, Bolpur, West Bengal, India,
and by the Institutional Ethics Committee of the Visva-
Bharati University, Santiniketan- 731 235, West Bengal,
India. Before taking blood samples, written consents were
obtained from normal and infected persons.
Blood samples
This study was carried out on the population residing in a
filarial endemic region and suffering from bancroftian fil-
ariasis. The study originated and was carried out while LF
was being studied for its prevalence and a clinical trial was
being conducted by Gayen et al. [22,23]. As reported
previously [22,23], all filarial patients were screened for
the presence of microfilaria of W. bancrofti in microscopic
preparation from finger-prick blood samples, which
formed a thick film over a glass slide and was followed
by Giemsa staining. Initially, the study involved the
entire population mentioned in the LF prevalence study
conducted between 2006 and 2008 by Gayen et al.
[22,23]. Later, a total of 62 individuals from 31 endemic
villages from the districts of Bankura and Birbhum were
again studied between 2011 and 2012. All the patients
Table 1 Oligonucleotide primers used for the PCR-based
identification of the fungal isolate and Wolbachia
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per 20 μl of nocturnal blood. Nocturnal blood samples
were collected at random from two apparently healthy
microfilaraemic patients, irrespective of sex and age,
from each village. In addition, blood samples were also
collected from 10 endemic normal individuals (five male
and five female; age 30 ± 2), who had no mf in their noc-
turnal blood samples or circulating filarial antigen, but
who resided in the same geographical location. During
blood sampling, aseptic conditions were maintained in
the laboratory to avoid contamination.
Isolation and co-culture of the parasite and yeast
Nocturnal blood samples (5 ml) were randomly collected
from the patients with or without P. guilliermondii, but
who screened for infection with W. bancrofti mf. Hepa-
rinized blood samples were diluted (1:1) with chilled
phosphate buffered saline (PBS, 10 mM sodium phosphate
buffer, 0.9% saline, pH 7.0) and centrifuged at 5,000 rpm
for five minutes at 25°C to pellet down the mf. The pellet
was suspended in 2 ml of culture medium containing
RPMI-1640 supplemented with 10% fetal bovine serum
(FBS), 1% glucose, 100 U/ml penicillin, 100 μg/ml strepto-
mycin, and 0.25 μg/ml amphotericin B, and cultured at
37°C with 5% CO2 for 10 minutes in a CO2 incubator.
Isolation and pure culture of P. guilliermondii
From the P. guilliermondii-W. bancrofti co-culture, 200 μl
of spent medium was inoculated in fresh medium and fur-
ther cultured for 48 hours at 37°C. Next, 10 μl of primary
culture was retrieved and observed under a phase contrast
microscope for presence of fungus (Dewinter, Italy). The in-
oculums from the medium were cultured and maintained
in said medium until pure culture was achieved in the yeast
specific medium. From the primary culture, 100 μl of inoc-
ulums were added to the pure culture medium comprising
modified YPD agar containing 2% peptone, 1% yeast ex-
tract, 2% dextrose, and 6% FBS [24], and cultured at 32°C
for 48 hours. After 11 consecutive sub-cultures, pure yeast
colonies were obtained and maintained for further studies.
DNA isolation, PCR amplification, and DNA sequencing
Existence of P. guilliermondii among filarial patients was
initially observed during the PCR diagnosis of W. bancrofti
using Wolbachia (an endosymbiont of W. bancrofti) spe-
cific primers, which are listed in Table 1. Following the
method described by Gayen et al. [22], DNA was isolated
from the mf rich blood samples. Molecular identification
of the W. bancrofti infection was determined by PCR-
based amplification of filaria and Wolbachia specific genes
(see Table 1). Multiple bands obtained from the amplifica-
tion of the Wolbachial gene (wsp) were sequenced and
showed the existence of metagenomic DNA of P. guillier-
mondii (detail is given in the Results section).In order to confirm the initial identification of the fun-
gal isolate as P. guilliermondii, yeast cells were grown
overnight on modified YPD broth at 32°C, with shaking
at 400 rpm. DNA was extracted and purified following
the procedures of Lee and Taylor [28]. Identification of
the fungal isolate was carried out through the amplifica-
tion of the highly-divergent D1/D2 region of 26S rRNA
of the yeast using the conserved primers (NL-1 and NL-
4) described previously [29]. All the primers along with
their nucleotide sequences and Tm are summarized in
Table 1. PCR was carried out for the amplification of 26S
rRNA gene of the fungal isolate under optimum amplifica-
tion conditions using a Gradient Thermocycler (Bio-Rad
laboratories, USA). Conditions applied for the PCR ampli-
fication were as follows: initial denaturation at 94°C for
four minutes followed by 30 cycles of 30 seconds at 94°C,
30 seconds at 48°C, one minute at 72°C, and a final elong-
ation step of five minutes at 72°C. The mixture contained
5 pmoles of each primer, 5 nmoles of dNTPs, 1.5U Taq
polymerase in its 1X buffer, and, 50 ng of DNA from the
yeast isolate in a final volume of 50 μl. Next, 2 μl was
checked in 1.8% agarose gel electrophoresis in a 1X Tris-
Borate-EDTA buffer. After running for two hours at
120 V, the gel was stained in an ethidium bromide bath,
de-stained in water, and observed under UV illumination
using Gel Doc™ (Bio-Rad, USA). The PCR amplicon ob-
tained from the amplification of D1/D2 region of the 26S
rDNA gene using yeast specific NL-1 and NL-4 primers
was purified by gel extraction and subjected to automated
DNA sequencing using the commercial service available
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All the nucleotide sequences were submitted to GenBank
(www.ncbi.nlm.nih.gov) using Sequin software.
In silico phylogenetic analysis
The isolated organism was formally identified by a BLASTn
search using the sequenced DNA against sequences in
existing DNA databases of reported organisms compiled by
the NCBI (www.ncbi.nlm.nih.gov). The BLASTn program
(www.ncbi.nlm.nih.gov) was used to align 26S rDNA se-
quence of the isolate to find the closest homologs. A
total of 16 different yeast species, including P. guillier-
mondii, were subjected to pair wise and multiple se-
quence alignment using the ClustalW program [30]. An
unrooted phylogenetic tree was constructed for 26S
rDNA using the maximum parsimony method employ-
ing the subtree pruning and regrafting (SPR) algorithm
[31] provided in the software package MEGA 5.1 [32].
The SPR algorithm operated with search level 0 in which
the initial trees were obtained by the random addition of
sequences (10 replicates). Included codon positions were
1st + 2nd + 3rd +Noncoding; the positions containing gaps
and missing data were eliminated. Furthermore, reliability
of the maximum parsimony tree was tested by the boot-
strap method (500 replicates), provided by the software
package MEGA 5.1 [32].
Screening for pathogenicity
Pathogenicity of the fungal isolate was determined by
the PCR-based detection of RPS0 gene previously de-
scribed by Martinez et al. [24]. Selective amplification of
the RPS0 gene was carried out using the primers (see
Table 1) designed for the RPS0 exon region for P. guil-
liermondii by Martinez et al. [24].
Scanning electron microscopy (SEM)
Yeast cells were isolated by centrifugation and processed
for SEM analysis following the method described by
Hayat [33], with some modifications. In brief, cell pellets
were suspended in cold phosphate buffer (50 mM,
pH 7.0) and incubated after adding 2.5% glutaraldehyde
(Merck, Germany) for 24 hours at 4°C for fixation. Fixed
cells were dehydrated by graded ethanol (10–99.9%;
Merck, Germany) at room temperature (25 ± 5ᵒC) and
coated with 99.9% pure gold using a sputter gold coater,
scanned and observed using a Scanning Electron Micro-
scope (Hitachi, Japan).
Determination of antibiotic sensitivity
The antimicrobial profile of the isolated fungal strain
was determined by the disc diffusion method on modi-
fied YPD agar plates (with serum) using freshly-prepared
inoculums from the exponential phase of the growth.
Antibiotic susceptibility of the yeast isolate was testedusing azole antifungals (fluconazole, clotrimazole, vori-
conazole, posaconazole and miconazole), griseofulvin,
amphotericin B, nystatin, nikkomycin Z, terbinafine, cas-
pofungin, and cycloheximide. The antimicrobial discs
were applied on the fungal culture plates and incubated
at 32°C for 24 hours. The inhibition zone appearing
around each disc was measured and the sensitivity was de-
termined from the zone diameter appearing on the plate
following CLSI (formerly NCCLS) guidelines [34]. A zone
with diameter of less than 13 mm in the presence of an
antimicrobial was interpreted as resistant, a zone with a
diameter of 15–16 mm was considered as having inter-
mediate sensitivity, and a clear zone with a diameter of
17 mm or more indicated a high degree of sensitivity to-
wards that antimicrobial. All the data were representative
of five independent observations.
Prevalence of P. guilliermondii among microfilaraemic
patients
Prevalence is a common epidemiological measure of any
infectious disease in a population. Since we have studied
the prevalence of LF caused by the W. bancrofti infec-
tion in the two districts of West Bengal [22], it was in-
teresting to study the prevalence of this typical fungal
infection in the microfilaraemic patients under investiga-
tion. We have investigated the occurrence of the P. guil-
liermondii infection among 222 microfilaraemic patients
(infected with W. bancrofti) in 32 different filarial endemic
villages in two rural districts (Birbhum and Bankura) of
West Bengal. The % prevalence was calculated by dividing
the number of persons who harbor the W. bancrofti-P.
guilliermondii co-infection by the number of microfilarae-
mic individuals who have W. bancrofti but not P. guillier-
mondii, and then multiplying this number by 100. To
study the prevalence of P. guilliermondii, both molecular
identification and culture analysis were employed to avoid
artifact in the result.
Statistical analysis
Statistical analysis was performed using GraphPad Prism
5.0 and Minitab 16 in the Windows environment. The dif-
ference between experimental data were analyzed by two-
way ANOVA and further confirmed by the Tukey’s test.
Results
Molecular identification of P. guilliermondii
Identification of infectious agents through PCR diagnosis
provides a feasible option for the correct identification
of such pathogens, as well as of the accurate therapeutic
strategies that can be used to treat them. The result of
PCR and DNA sequencing based molecular identifica-
tion studies revealed the fungal isolate as P. guilliermon-
dii (see Table 2 and Figure 1). As we have mentioned in
the introduction, during identification of Wolbachial








630 bp NTS1, 5S rRNA gene, and partial NTS2. 96%
identity with reference sequence (accession
no: FN554234.1).
KC970159
540 bp D1/D2 region of 26S rDNA. 99.9% similarity
with the reference nucleotide sequence
(accession no: JX649967.1)
KC771883
504 bp 83% identical with the reference partial
mRNA sequence of hypothetical protein
(accession no: XM_001482915.1).
KC970158
252 bp 61% similarity with the reference partial
mRNA sequence of hypothetical protein
(accession no: XM_001486685.1).
KC970157
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of the wsp gene (a routine technique for determining
the W. bancrofti infection), almost in every case three
different amplicons (size: 252, 504, and 630 bp), apart
from the wsp amplicon (590 bp), were evident in the agar-
ose electrophoresis (see Figure 1A). These amplicons were
sequenced and subjected to a similarity search using theFigure 1 Molecular identification and phylogeny of P. guilliermondii is
of 18S rDNA of W. bancrofti, Wolbachial 16S rDNA, and Wolbachia surface p
amplicon, L2: Amplified 16S rDNA of Wolbachia, L3: wsp-int specific amplic
26S rDNA of P. guilliermondii. C. Agarose gel showing PCR amplicon of P. g
Maximum Parsimony analysis of the phylogenetic relationship between P. g
on the branches of the tree indicate % bootstrap value (BV). In the tree, BV
representative of experiments carried out in triplicates and repeated at leasBLASTn program that showed 99% similarity with 5.8S
rDNA, 99% of partial 26S rDNA, and NTS1 (Ribosomal
Non Transcribed Spacer 1), 5S rRNA gene and partial
NTS2 of P. guilliermondii (see Table 2). These preliminary
results have prompted us to identify the fungus from its
pure culture. The PCR amplification of isolated DNA with
yeast specific universal primers produced an amplicon of
highly-conserved D1/D2 region of 26S rDNA of approxi-
mately 540 bp size that primarily identified the organism
as yeast (see Figure 1B and Table 2). This finding was
verified thrice and the amplicon was sequenced. BLASTn
analyses of nucleotide sequences obtained from DNA se-
quencing using yeast specific universal NL-1 (forward)
and NL-4 (reverse) primers showed a high degree (≥ 99%)
of similarity with yeast specific 26S rDNA for P. guillier-
mondii (C. guilliermondii or M. guilliermondii), available
in NCBI database (GenBank accession no: JX649967.1)
(Table 2). Moreover, pair wise alignment of the sequenced
DNA with reference 26S rDNA sequence of Pichia sp.
(GenBank accession no: JX951173) showed 99% and 100%
identity, respectively, for forward and reverse primer-
based sequenced DNA (data not shown). The partial se-
quencing of the D1/D2 region of 26S rDNA furtherolated from filarial patients. A. Agarose gel showing PCR amplicon
rotein. M: DNA ladder (100 bp to 3 kb), L1: filarial 28S rDNA specific
on. B. Agarose gel representing the PCR amplicon of D1/D2 region of
uilliermondii DNA amplified with RPS0 gene specific primers. D.
uilliermondii and some common yeast species. The numerals given
values less than 50 were considered low. Figure A, B, and C are the
t five times.
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registered in GenBank with the accession no. KC771883
(see Table 2). As demonstrated in Figure 1C, an ampli-
con size of approximately 610 bp of RPS0 indicated the
pathogenicity of the isolate. Since the primers were de-
signed from the RPS0 exon, one can therefore conclude
that the RPS0 gene exists as exon in P. guilliermondii.
Interestingly, the intensity and pattern of pathogenicity
of P. guilliermondii is different from C. albicans, which
might be due to the dissimilarity in the RPS0 gene se-
quence [24].
Major pathogenic Candida spp. including our isolate
along with S. cerevisiae, which were positioned distinctly
in the phylogenetic tree based on 26S rDNA, resembled
C. albicans and C. tropicalis, respectively, as the closest
and the most distant neighbor of P. guilliermondii (see
Figure 1D). The phylogenetic tree out of the six most
parsimonious trees (length = 141) is shown in Figure 1D.
The consistency index is 0.773050 (0.757576), the reten-
tion index is 0.853881 (0.853881), and the composite
index is 0.660093 (0.646880) for all sites and parsimony-
informative sites (in parentheses) (see Figure 1D). Boot-
strapping values (% BVs) suggested that the genus
Candida is not a monophyletic group and the species
can be categorized into four monophyletic groups basedFigure 2 Micrographs of P. guilliermondii isolated from the blood stre
endemic districts in West Bengal, India. A. Phase contrast micrograph sh
co-cultured for a period of 24 hours. B. Phase contrast micrograph showing
condition in pure culture. C. Scanning electron micrograph showing typica
Scanning electron micrograph showing fungal pseudohyphae after 72 houon BV% (see Figure 1D). The first group (BV 56%)
constitutes two species pairs in which C. albicans/C.
guilliermondii (P. guilliermondii) were phylogenetically
close with BV 41% (see Figure 1D). Thus, the bootstrap
test also supported the result of the maximum parsi-
mony analysis. As demonstrated by Hillis and Bull [35],
BV 70% is considered to indicate well-established groups.
In this tree, the pair comprising C. sake/P. caribbica was
inferred as a well-supported monophyletic group ac-
cording to the bootstrap test (BV 99%), as depicted in
Figure 1D. It is also worth noting that the C. orthopsilo-
sis/C. tropicalis pair appeared as a cluster with a low BV
(29%) (see Figure 1D).
Microscopic characterization of P. guilliermondii
Microscopic characterization is a conventional technique
for microbial characterization. Figure 2A depicts the phase-
contrast micrograph showing P. guilliermondii along with
the mf of W. bancrofti in a co-culture, where both were vi-
able. The characteristic microscopic morphology of the
fungus was similar in both the co-culture and in the pure
culture (see Figure 2A and B). Electron micrograph of P.
guilliermondii showed characteristic single-cell morphology
of P. guilliermondii (see Figure 2B) and the micrograph was
similar with a previous report [36]. However, microbesam of microfilaraemic patient residing in the two studied filarial
owing P. guilliermondii cells with W. bancrofti after they have been
characteristic morphology of P. guilliermondii grown under optimum
l single cell morphology of P. guilliermondii grown in pure culture. D.
rs of growth in pure culture on modified YPD agar.
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branched pseudohyphae of the isolate cultivated on YPD
agar (see Figure 2D) and the morphology of hyphae was
also supported by a previous report [37].The antibiotic sensitivity profile of the isolate
The fungal isolate described in this study showed resist-
ance to common antifungals including azoles. The anti-
biotic sensitivity profile of P. guilliermondii is given in
Figure 3. It showed resistance to all azole antifungals,
griseofulvin, and amphotericin B (see Figure 3A and B),
whereas nystatin, nikkomycin Z, terbinafine, caspofungin,
and cycloheximide were found to be effective against the
isolate at a concentration of 10 μg/ml (see Figures 3B
and C). These observations were corroborated by previous
studies by Pfaller et al. [17,38]. Among those effective an-
tifungals, nystatin and cycloheximide were the antifungals
of choice with inhibition zones of 45 mm and 37.5 mm,
respectively, whereas activity of other three drugs were
moderate at a concentration of 10 μg/ml. MIC values for
these most effective antimicrobials were 5.7 and 7.2 μg/
ml, respectively for nystatin and cycloheximide.Prevalence of P. guilliermondii among microfilaraemic
patients
We found high prevalence (88.7%) of the P. guilliermon-
dii infection in microfilaraemic patients co-existing with
filarial parasite. Out of the 222 microfilaraemic patients
studied, 197 showed the P. guilliermondii co-infection,
whereas the rest were devoid of the P. guilliermondii
infection (see Figure 4). As shown in Figure 4A and B,
88 out of 100 microfilaraemic patients in Bankura
and 109 out of 122 microfilaraemic patients in the
Birbhum district showed parasite-fungus co-infection.Figure 3 Antibiotic sensitivity of P. guilliermondii grown in presence o
showed resistance to voriconazole (VOR), griseofulvin (GRI), and miconazole
amphotericin B (AMB) and posaconazole (POS). B. The fungal isolate showe
whereas detectable susceptibility was evident for nystatin (NYS) and cycloh
respectively. C. Caspofungin (CAP), nikkomycin Z (NIK), and terbinafine (TER
1.5, and 15.0 ± 1.5 mm, respectively. Experiments were carried out in triplic
dose of 10 μg/ml.The difference between the number of microfilaraemic
patients and microfilaraemic patients having the P. guil-
liermondii co-infection was not statistically significant
(p > 0.05). Therefore, microfilaraemic patients were likely
to acquire the P. guilliermondii co-infection in the men-
tioned areas. However, individuals without a filarial infec-
tion (endemic normal) did not show any such infection.
Moreover, a large number of patients did not possess any
detectable symptom externally.Discussion
Bancroftian filariasis, caused by the W. bancrofti infec-
tion, covers about two-thirds of the global filarial popu-
lation [39]. This form of filariasis is considered to be an
important public health issue in India [39]. The disease
is very ancient in the country as evident from the two
oldest medical books of India namely the Susruta Samhita
(6th century BC), and the Rug-vinischaya, also known as
the Nidāna, written by the physician Madhava-kara (7th
century AD) [3]. The endemic map constitutes 20 states
and six UTs in India, where 23 million people are suffering
from the disease, 31 million are mf carriers, and about 553
million are at risk of infection [3]. Previously, we have re-
ported the prevalent status of bancroftian filariasis in the
filarial endemic rural areas of the two districts, Bankura
and Birbhum, in West Bengal, India [22].
Individuals suffering from bancroftian filariasis exhibit
demonstrable clinical pathology that includes lymphedema,
hydrocele, and elephantiasis [39]. Progressive lymphatic
damage and pathology caused by the filarial parasite is due
to immense tissue alteration and immunomodulation,
which also promotes secondary infection by bacteria
and fungus [40,41]. Previous researchers have reported
bacterial and fungal co-infections in LF patients duringf common antifungals on YPD agar Plate. A. P. guilliermondii
nitrate (MIN), whereas mild susceptibility (<5 mm) was observed for
d resistance to both fluconazole (FLU) and clotrimazole (CLO),
eximide (CYC), with inhibition zones of 45.0 ± 2.5 and 37.5 ± 2.3 mm,
) were found to be effective with inhibition zones of 22.5 ± 2.0, 20.0 ±
ates and all the antifungal drugs were tested for susceptibility at a
Figure 4 Prevalence study of P. guilliermondii co-infection in microfilaraemic patients. A. P. guilliermondii-W. bancrofti co-infection among
the microfilaraemic patients of the Bankura district, India. B. P. guilliermondii-W. bancrofti co-infection among the microfilaraemic patients living in
the filarial endemic villages of the Birbhum district, India.
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http://www.idpjournal.com/content/3/1/13the progression of elephantiasis [18,19,21]. However,
the study of the diagnosis of fungal co-infection has
been neglected to date.
Co-infection is a very important topic in relation to
human health and still lacks a lot of epidemiological and
experimental data. To date, there are very few re-
searchers who have studied the co-infections associated
with any form of filariasis. There has been a report of
co-infection with filarial parasites and Mycobacteria or
Plasmodium spp. in filarial patients, which indicated that
immunomodulation and suppression of pro-inflamma-
tory response are the principal reasons behind such
co-infection [20]. However, fungal co-infection with
bancroftian filariasis has not been reported to date. Our
experimental and epidemiological data revealed the
occurrence and molecular identification of non-albicans
Candida (P. guilliermondii) co-infection in a statistically
significant number of individuals suffering from bancrof-
tian filariasis.
The identification of P. guilliermondii-W. bancrofti co-
infection in microfilaraemic individuals and its prevalence
were studied using PCR-based molecular diagnosis.
The method of choice for molecular diagnosis of ban-
croftian filariasis is the PCR-based selective amplification
of the Wolbachia (a filarial endosymbiont) specific gene
(wsp int gene). Interestingly, during the study of the LF
prevalence in the mentioned districts, in most of the
cases (88.7%), we observed three intense bands of 630,
504, and 252 bp, along with the wsp amplicon (590 bp).
After sequencing all the bands, we came to the conclu-
sion that, apart from wsp, the nonspecifically amplified
bands belonged to a fungus i.e. P. guilliermondii (see
Table 2). All the DNA sequences obtained from the
bands shared significant similarities (up to 90%) with P.
guilliermondii, which is synonymous to C. guilliermondii
or M. guilliermondii [42]. Existence/appearance of such
fungal metagenomic DNA in a number of occasions had
prompted us to identify and investigate the occurrenceof this organism in filarial patients. Amplification and
sequencing of the D1/D2 region of the 26S rRNA
gene from fungal DNA, followed by a similarity
search using BLASTn, confirmed that the organism is
P. guilliermondii. Molecular identification based on
D1/D2 region of the 26S/28S rRNA gene is a reliable
and robust means for identifying clinically relevant
yeast isolates [43]. This PCR amplification based
identification is specific, sensitive and does not in-
volve complex and expensive equipment [24]. Sequen-
cing of the internal transcribed regions (ITS) of the
nuclear rRNA gene had especially been used to iden-
tify and discriminate between 40 species of medically
important yeasts [44]. These regions have evolved
slowly and show high degrees of conservation among
fungi, and are thus used for molecular identification
and to study the phylogenetic relationships among
the isolates [43]. In this study, the phylogenetic tree
based on D1/D2 region of 26S rDNA sequence of
P. guilliermondii and its close neighbors presented a
comprehensive view of their distribution, as well
as their evolutionary relationship (see Figure 1D). P.
guilliermondii was placed closely with C. albicans in
the tree. However, the position of P. guilliermondii-C.
albicans was supported by a low bootstrap value (BV
% 41). In addition, selective amplification of the RPS0
gene with P. guilliermondii specific PCR primers fur-
ther supported our finding. An amplicon of 620 bp
(approximately) indicated the pathogenicity of the iso-
lated species, and this finding corroborates with a
previous report [24]. Screening of pathogenicity
through a selective amplification of RPS0 has been
reported as an efficient approach for the determin-
ation of pathogenicity of yeast isolates from a clinical
specimen [24]. Identification and differentiation of
pathogenicity of a number of Candida spp., including
P. guilliermondii, by selective amplification of RPS0
has been reported previously [45].
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varies greatly and the widespread use of antifungals might
have contributed to the alteration in the species distribu-
tion through antibiotic resistance [13]. According to our
study, P. guilliermondii tends to be resistant to common
antifungals (mostly azoles). Therefore, treatment with an
appropriate antifungal is required to improve survival
rates in these patients. Previously, we have reported effect-
ive combinatorial chemotherapy using doxycycline (an
antibacterial antibiotic) and albendazole (an anthelmintic)
for the control of bancroftian filariasis in India [23]. How-
ever, neither of these drugs could eliminate this secondary
infection. In vitro susceptibility of the isolate suggested
that nystatin or cycloheximide could be the drugs to
treat this fungal co-infection in filarial patients. Exten-
sive in vivo studies and clinical trials are welcome to
optimize the dose and duration needed to treat patients.
The high prevalence of P. guilliermondii in W. bancrofti
infected individuals, inferred through first-time experi-
mental findings, establishes the occurrence of the yeast-
filarial parasite co-infection in India. Therefore, the study
provides the platform to investigate the role of such co-
infection in pathology and disease progression in LF.
Conclusion
We address the PCR-based molecular identification and
association of a yeast species i.e. P. guilliermondii co-
infection in a significant number of individuals suffering
from lymphatic filariasis in the districts of Birbhum and
Bankura, West Bengal, India. The findings showed the
presence of a new species of fungus in bancroftian filar-
ial patients. These findings are particularly important in
relation to human health, especially for filarial patients.
Investigations of the P. guilliermondii and W. bancrofti
co-infection in other endemic zones (involving a large
number of patients), to arrive at a molecular under-
standing of the two species, are currently underway.
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